Concentration of IL-10, IL-13 and IFN-γ cytokines in supernatants of microcultured CD4 and NK cells in patients with non-allergic bronchial + asthma;Stȩżenie cytokin IL-IO, IL-13 i IFN-γ w nadsqczach hodowli komórek CD4+ i NK u chorých na niealergiczna̧ astmȩ oskrzelowa̧

Polski Merkuriusz Lekarski

Volumn 24, Issue 139, 2008, Pages 8-13

  Stasiak Barmuta, Anna ^a,d   Stankiewicz, Wanda ^a,e   Chciatowski, Andrzej ^b,f   Moniuszko, Tadeusz ^a,g   Alifier, Marek ^c  

^a Przeplywowej Cytometrii Przeplywowej ^*

^b MILITARY INSTITUTE OF MEDICINE   (Poland)

^c MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

^d Capillaroscopy Laboratory   (Poland)

^e MILITARY INSTITUTE OF HYGIENE AND EPIDEMIOLOGY   (Poland)

^f CENTRAL CLINICAL HOSPITAL   (Poland)

^g District General Hospital Bialystok   (Poland)

Author keywords

Cell culture; Cytokines; Non allergic asthma; T lymphocytes

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 13;

ADULT; ARTICLE; ASTHMA; BRONCHUS HYPERREACTIVITY; CD4+ T LYMPHOCYTE; FEMALE; HUMAN; IMMUNOLOGY; INFECTION; MALE; MIDDLE AGED; NATURAL KILLER CELL; RECURRENT DISEASE; VIRUS INFECTION;

ADULT; ASTHMA; BRONCHIAL HYPERREACTIVITY; CD4-POSITIVE T-LYMPHOCYTES; FEMALE; HUMANS; INFECTION; INTERLEUKIN-10; INTERLEUKIN-13; KILLER CELLS, NATURAL; MALE; MIDDLE AGED; RECURRENCE; VIRUS DISEASES;

EID: 39049089933     PISSN: 14269686     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. Agarwal S.K., Marshal G.D.: Beta-adrenergic modulation of human type1/ type 2 cytokine balance. J. Allergy Clin. Immunol., 2000, 105, 91-98.
2. Barnes P.J., Lim S.: Inhibitory cytokines in asthma. Molecul. Med. Today, 1998, 4 (10), 452-458.
3. + lymphocytes. J. Immunol., 1997, 158, 5589-5595.
4. Body K.J., Semper A.E., Redington A.E. i wsp.: Cytokine profiles of BAL T cells and T-cell clones obtained from human asthmatic airways after local allergenchallenge. Allergy, 1999, 54, 1083-1093.
5. Cherwinski H.M., Schumacher J.H., Brown K.D., Mosmann T.R.: Two types of mause helper T-cell clone. Futher differences in lymphokine synthesis between Th 1 and Th2 clones revealed by RNA hybridization, functional monospecific bioassays and monoclonal antibodies. J. Exp. Med., 1987, 166, 1229-1244.
6. Chretien I., Pene J., Briere F. i wsp.: Regulation of human IgE synthesis. I. Human IgE synthesis in vitro is determined by the reciprocal antagonistic effects of interleukin-4 and interferon-γ. Eur. J. Immunol., 1990, 20, 243-251.
7. Chung F.: Anti-inflammatory cytokines in asthma and allergy: interleukin10, interleukin-12, interferon-gamma. Mediators lnflamm., 2001, 10(2), 51-59.
8. De Vries J.E.: Molecular and biological characteristics of interleukin-13. Chem. Immunol., 1996, 63, 204-218.
9. De Waal Malefyt R., Abrams J.S., Zurawski S.M. i wsp.: Differential regulation of IL-13 and IL-4 production by human CD8+ and CD4+ ThO, Th 1, Th2 cell clones and EBV-transformed B cells. Int. Immunol., 1995, 7, 1405-1416.
10. De Waal Malefyt R., Figdor C., Huybens R. i wsp.: Effects IL-13 on phenotype, cytokine production and cytotoxic function of human monocytes: comparison to IL-4 and modulation by IFN-γ or IL-10. J. Immunol., 1993, 151, 6370-6381.
11. Dunne J., Lynch S., O'Farrelly C i wsp.: Selective expansion and partial activation of human NK cells and NK receptor-positive T cells by IL-2 and IL-15. J. Immunol., 2001, 167, 3129-3138.
12. Ford J.G., Rennick D., Donaldson D.D. i wsp.: IL-13 and IFN-γ interaction in lung inflammation. J. Immunol., 2001, 167, 1769-1777.
13. Grunig G., Warnock M., Wakil A.E. i wsp.: Requirement for IL-13 independently of IL-4 in experimantal asthma. Science, 1998, 282, 2261-2263.
14. Heydeck D., Thomas L., Schnurr K. i wsp.: lnterleukin-4 and -13 induce upregulation of the murine macrophage 12/15-lipoxygenase activity: evidence for the involvement of transcription factor STAT6. Blood, 1998, 92, 2503-2510.
15. Ho A.S., Moore K.W.: lnterleukin-10 and its receptor. Ther. Immunol., 1994, 1, 173-185.
16. Hoekstra M.O., Hoekstra Y., de Reus D. i wsp.: lnterleukin-4, interferonγ and interleukin-5 in peripheral blood of children with moderate atopic asthma. Clin. Exp. Allergy, 1997, 27, 1254-1260.
17. Humber M., Ying S., Corrigan G.J. i wsp.: Bronchial mucosal expression of the genes encoding chemokines RANTES and MCP-3 in symptomatic atopic and non-atopic asthmatics: relationship to the eosinophil-active cytokines interleukin-5 (IL-5), granulocyte macrophage-colony-stimulating factor and IL-13. Am. J. Respir. Cell Mol. Biol., 1997, 16, 1-8.
18. Humbert M., Durham S.R., Kimmitt P. i wsp.: Elevated expression of messenger ribonucleic acid encoding IL-13 in bronchial mucosa of atopic and nonatopic subjects with asthma. J. Allergy Clin. Immunol., 1997, 99, 657-665.
19. Katsuyuki T., Lim S., Hanazawa T. i wsp.: Attenuated production of intracellular IL-10 and IL-12 in monocytes from patients with severe asthma. Clin. Immunol., 2002, 102(3), 258-266.
20. Kotsimbos T.C., Ernst P., Hamid Q.A.: lnterleukin-13 and interleukin-4 are coexpressed in atopic asthma. Oroc. Assoc. Am. Physicians, 1996, 108, 368-373.
21. Krug N., Erpenbeck V.J., Balke K. i wsp.: Cytokine profile of bronchoalveolar lavage-derived CD4(+), CD8(+), and gammadelta T cells in people with asthma after segmental allergen challenge. Am. J. Respir. Cell Mol. Biol., 2001, 25(1), 125-131.
22. Lack G., Bradley K.L., Hamelmann E. i wsp.: Nebulized IFN-gamma inhibits the development of secondary allergic responses in mice. J. Immunol., 1996, 157, 1432-1439.
23. Lamblin C., Desreumaux P., Colombel J-F., Tonnel A-B., Wallaert B.: Overexpression of IL-10 mRNA in gut mucosa of patients with allergic asthma. J. of All. & Clin. Immunol., 2001, 107(4), 739-741.
24. Lang R., Rutschman R.L., Greaves D.R., Murray P.J.: Autocrine deactivation of macrophages in transgenic mice constitutively overexpressing IL-10 under control of the human CD68 promoter. J. Immunol., 2002, 168, 3402-3411.
25. Leuwerys B.R., Garot N., Renauld J-Ch., Houssiau F.A.: Cytokine production and killer activity of NK/T-NK cells derived with IL-2, IL-15, or the combination of IL-12 and IL-18. J. Immunol., 2000, 165, 1847-1853.
26. Luttmann W., Matthiesen T., Matthys H., Virchow Jr J.C.: Synergistic effects of interleukin-4 or interleukin-13 and tumor necrosis factor-a on eosinophil cells. Am. J. Respir. Cell Mol. Biol., 1999, 20, 474-480.
27. Magnan A.O., Mely L.G., Camilla C.A. i wsp.: Assessment of the Th1/Th2 paradigm in whole blood in atopy and asthma. Increased IFN-γ -producing CD8+ T cells in asthma. Am. J. Respir. Crit. Care Med., 2000, 161, 1790-1796.
28. Minty A., Chalon P., Derocq J.M. i wsp.: lnterleukin-13 is a new human lymphokine regulating inflammatory and immune responses. Nature, 1993, 362, 248-250.
29. Montaner L.J., Doyle A.G., Collin M. i wsp.: lnterleukin-13 inhibits human immunodeficiency virus type 1 production in praimary blood-derived human macrophage in vitro. J. Exp. Med., 1993, 178, 743-747.
30. Monteiro J., Trinchieri G.: Does IL-12 play a role in the viral immune response? Ann. NY Acad. Sci., 1996, 795, 366-367.
31. Nurse B., Hauss M., Puterman A.S., Weiberg E.G., Potter P.C.: Reduced interferon-g but normal IL-4 and IL-5 release by peripheral blood mononuclear cells from Xhosa children with atopic asthma. J. Allergy Clin. Immunol., 1997, 100, 662-668.
32. Nutku E., Gounni A. S., Olivenstein R., Hamid Q.: Evidence for expression of eosinophil-associated IL-12 messenger RNA and immunoreactivity in bronchial asthma. J. Allergy Clin. Immunol., 2000, 106(2), 288-292.
33. Ochiai K., Tanabe E., Ishihara C. i wsp.: Role of JAK2 signal transductional pathway in activation and survival of human peripheral eosinophils by interferon-gamma (IFN-γ). Clin. Exp. Immunol., 1999, 118, 340-343.
34. Pretolani M., Goldman M.: IL-10: a potential therapy for allergic inflammation? Immunol. Today, 1997, 18, 277-280.
35. Renzi P.M., Turgeon J.P., Marcotte J.E. i wsp.: Reduced interferon-g production in infants with bronchiolitis and asthma. Am. J. Respir. Crit. Care Med., 1999, 159, 1417-1422.
36. Rosenthal L.A., Mikus L.D., Sorkness R.L., Lemanske Jr R.F.: Reduced proliferation and interferon-γ production by CD8+ T lymphocytes in rats susceptible to the development of a post-viral asthma-like phenotype. J. Allergy Clin. Immunol., 2000, 105, S294.
37. Spencer S.D., Di Marco F., Hooley J. i wsp.: The orphan receptor CRF2-4 is an essential subunit of the interleukin-10 receptor. J. Exp. Med., 1998, 187, 571-578.
38. Spiteri M.A., Knight R.A., Jeremy J.Y., Barnes P.J., Chung K.F.: Alveolar macrophage-induced suppression of peripheral blood mononuclear cell responsiveness is reversed by in vitro allergen exposure in bronchial asthma. Eur. Respir. J., 1994, 7, 1431-1438.
39. Stasiak-Barmuta A., Rutkowski R., Stankiewicz W., Moniuszko T., Pawtowski P.: Ocena wewna̧trzcytoplazmatycznych receptorów cytokinowych IFN-(gamma) i IL-4 u dzieci z odczynami bronchospastycznymi. Arch. Med. Res., 2003, 1, 37.
40. Tang M.L.K., Kemp A.S., Thorburn J., Hill J.: Reduced interferon-g secretion in neonates and subsequent atopy. Lancet, 1994, 344, 983-985.
41. Ten Hacken N.H.T., Oosterhoff Y., Kauffman H.F i wsp.: Elevated serum interferon-y in atopic asthma correlates with increased airways responsiveness and circadian peak expiratory flow variation. Eur. Respir. J., 1998, 11, 312-316.
42. Trinchieri G.: Cytokines acting on or secreted by macrophages during intracellular infection (IL-10, IL-12, IFN-γ). Curr. Opin. Immunol., 1997, 9, 17-23.
43. Turner D.M., Williams D.M., Sankaran D. i wsp.: An investigation of polymorphism in the interleukin-10 gene promoter. Eur. J. Immunogenet., 1997, 24, 1-8.
44. Van der Pouw Kraan T.C.T.M., Boeijle L.C.M., de Groot E.R., Stapel S.O., Snijders A., Kapsenberg M.L.: Reduced production of IL-12 and IL-12 dependent IFN-γ release in patients with allergic asthma. J. Immunol., 1997, 158, 5560-5565.
45. Vieira P.L., Kalinski P., Wierenga E.A., Kapsenberg M.L., de Jong E.C.: Glucocorticoids inhibit bioactive IL-12p70 production by in vitro-generated human dendritic cells without affecting their T-cell stimulatory potential. J. Immunol., 1998, 161, 5245-5251.
46. Wills-Karp M.: IL-12/IL-13 axis in allergic asthma. J. Allergy Clin. Immunol., 2001, 107(1), 9-18.
47. Wang P., Wu P., Siegel M.I., Egan R.W., Billah M.M.: lnterieukin (IL)-10 inhibits nuclear factor KB activation in human monocytes. IL-10 and IL-4 supress cytokine synthesis by different mechanisms. J. Biol. Chem., 1995, 270, 9558-9563.
48. Wong C. K., Ho C. Y., Ko F. W. S. i wsp.: Proinflammatory cytokines (IL17, IL-6, IL-18 and IL-12) and Th cytokines (IFN-[gamma], IL-4, IL-10 and IL-13) in patients with allergic asthma. Clin. Exp. Immunol., 2001, 125(2), 177-183.
49. Yoshida M., Watson R.M., Rerecich T., O'Byrne P. M.: Different profiles of T-cell /FN-[gamma] and IL-12 in allergen-induced early and dual responders with asthma. J. Allergy Clin. Immunol., 2005, 115(5), 1004-1009.
50. Yu C.R., Kirken R.A., Malabarba M.G., Young H.A., Ortaldo J.R.: Differential regulation of the Janus kinase-STAT pathway and biologic function of IL-13 in primary human NK and T cells: comparative study with IL4. J. Immunol., 1998, 161, 218-227.
51. Zuany-Amorim C., Haile S., Leduc D., Dumarey C., Huerre M., Vargaftig B.B., Pretolani M.: Interleukin-10 inhibits antigen-induced cellular retirement into the airway of sensitized mice. J. Clin. Invest., 1995, 95, 2644-2651.